title: Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma.
abstract: OBJECTIVE
  To identify complications associated with tumor-related lipid exudation (TRLE) after plaque radiotherapy of posterior uveal melanoma.
  
  
  METHODS
  Comparative study including 294 patients with posterior uveal melanoma who developed TRLE after plaque radiotherapy (TRLE group) and 294 patients who did not develop TRLE (non-TRLE group). Patients in the TRLE group were matched with patients in the non-TRLE group for age, gender, and initial tumor thickness.
  
  
  RESULTS
  The TRLE group was associated with significantly higher incidence of postradiation complications including early transient increase of serous retinal detachment (p<0.001), iris neovascularization (NVI) (p<0.001), neovascular glaucoma (NVG) (p<0.001), posterior synechia (p<0.001), vitreous hemorrhage (p<0.001), subretinal hemorrhage (p<0.001), and retinoschisis (p<0.001). A significant relationship was found between extent of TRLE and NVI (p<0.001), NVG (p<0.001), posterior synechia (p = 0.007), and retinoschisis over tumor (p = 0.010). Radiation-induced retinopathy, maculopathy, and papillopathy were not associated with presence or extent of TRLE. Tumor-related lipid exudation was also associated with worse final visual acuity (p = 0.011), higher rate of secondary enucleation (p<0.001), and lower rate of systemic metastasis (p = 0.006).
  
  
  CONCLUSIONS
  Tumor-related lipid exudation following plaque radiotherapy of posterior uveal melanoma is associated with major intraocular complications and portends poor prognosis for final visual acuity and eye retention. These findings provide evidence for the presence of 2 distinct pathogenic mechanisms, one radiation-induced and one tumor-related, in development of postradiation complications in eyes with posterior uveal melanoma.
authors.affiliation: Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, 840 Walnut Street, Philadelphia, PA 19107, USA. arman_mash@yahoo.com
authors.forename: Arman
authors.initials: A
authors.lastname: Mashayekhi
authors.forename: Samuray
authors.initials: S
authors.lastname: Tuncer
authors.forename: Carol L
authors.initials: CL
authors.lastname: Shields
authors.forename: Jerry A
authors.initials: JA
authors.lastname: Shields
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy / Q000009:adverse effects*; D005122:Exudates and Transudates; D005128:Eye Diseases / Q000209:etiology*; D015353:Eye Enucleation; D005260:Female; D015355:Glaucoma, Neovascular / Q000209:etiology; D006801:Humans; D007498:Iris / Q000098:blood supply; D050356:Lipid Metabolism; D008297:Male; D008545:Melanoma / Q000150:complications* / Q000532:radiotherapy; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000209:etiology; D011832:Radiation Injuries / Q000209:etiology*; D012160:Retina / Q000528:radiation effects; D012164:Retinal Diseases / Q000209:etiology; D015996:Survival Rate; D014604:Uveal Neoplasms / Q000150:complications* / Q000532:radiotherapy; D014823:Vitreous Hemorrhage / Q000209:etiology; D055815:Young Adult; D000098943:Uveal Melanoma